Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of December 2019, with a specific transaction date of December 10, 2019. The report serves as a transaction notification regarding a Person Discharging Managerial Responsibilities (PDMR) rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to a specific share transaction notification.
- Transaction Type: Transfer of Ordinary Shares.
- Instrument: Ordinary shares of 25 pence each (ISIN: GB0009252882).
- Volume: 9,027 shares.
- Price: £0.00 (Nil consideration).
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details an internal transfer of 9,027 ordinary shares beneficially held for Mr. J Symonds (Non-Executive Chairman) from his Zeneca Retirement Capital Plan to his personal shareholding account.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is strictly a regulatory disclosure of a PDMR share transfer.
Investor Verification Points
- Verify the identity of the PDMR involved: Mr. J Symonds, Non-Executive Chairman.
- Confirm the nature of the transaction: A transfer from a retirement plan to a personal account for nil consideration.
- Note that this filing contains no financial performance data for the period.